Quarz is Highly Concerned that Sabana REIT's Continued Deterioration in Performance may Further Reduce DPU and Urges Sabana Directors Not to Waste Unitholders' Monies by Appointing an Independent Financial Advisor
SINGAPORE, Feb. 21, 2023 /PRNewswire/ -- Quarz Capital Management, Ltd today issued an open letter ...
The 10th Microfilm Production Support Scheme (Music) Matching & Launching Ceremony
Supporting 32 teams of local advertising production companies and singers to spark creativity toget...
Puxin Limited Announces Second Quarter 2021 Unaudited Financial Results
BEIJING, Dec. 29, 2021 /PRNewswire/ -- Puxin Limited (NYSE: NEW) ("Puxin" or the "Company"), a priv...
HanAll Biopharma Reports Q1 2024 Financial Results and Provides Business Update
* Delivered solid performance to start 2024, with record-breaking first quarter revenue of34.1 bi...
I-Mab Reports Financial Results for the Six Months Ended June 30 and Provides Corporate Update
Positive preliminary clinical trial results for lemzoparlimab (TJC4) demonstrate a differentiated d...
Cango Inc. Reports Second Quarter 2020 Unaudited Financial Results
SHANGHAI, Aug. 24, 2020 /PRNewswire/ -- Cango, Inc. (NYSE: CANG) ("Cango" or the "Company"), a lead...
Prospector Capital Corp. Shareholders Approve Previously Announced Business Combination with LeddarTech
Record date for the previously announced issuance of one additional Prospector Class A Share for ea...
Hong Kong Oyster Culture Journey • Exploring Ocean Treasures • Inspiring Conservation Action: The Nature Conservancy's "The Oyster Odyssey Exhibition - Restoring Hong Kong's Lost Treasure"
HONG KONG, Nov. 10, 2023 /PRNewswire/ -- The Nature Conservancy's "The Oyster Odyssey - Restoring H...
European Commission Approves Menarini Group's ORSERDU® (Elacestrant) for the Treatment of Patients with ER+, HER2- Locally Advanced or Metastatic Breast Cancer with an Activating ESR1 Mutation
* Each year in Europe more than 550,000 patients are diagnosed with breast cancer, of whom 70% ha...
South Korea Ministry of Food and Drug Safety Approves Novavax COVID-19 Vaccine
GAITHERSBURG, Md., Jan. 12, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology comp...
Semaglutide in people with obesity: boosts wellbeing and ability to perform daily physical activities
BAGSVÆRD, Denmark, May 13, 2021 /PRNewswire/ -- Novo Nordisk today announced new results from the S...
Fang Announces Third Quarter 2020 Unaudited Financial Results
BEIJING, Nov. 13, 2020 /PRNewswire/ -- Fang Holdings Limited (NYSE: SFUN) ("Fang" or the "Company")...
AbbVie and I-Mab Enter into Global Strategic Partnership for Differentiated Immuno-oncology Therapy
NORTH CHICAGO, Illinois and SHANGHAI, China, Sept. 4, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV) and ...
The Winter Sports Expo 2019 Opens in Beijing as World's First Ice and Snow Exhibition to Aggressively Fuel the Upcoming Winter Olympics
BEIJING, Oct. 18, 2019 /PRNewswire/ -- On October 17, the World Winter Sports ( Beijing) Expo 2019 (...
GCL Asia signs Business Combination Agreement with RF Acquisition Corp to go public in a SPAC merger valuing the video game distributor & publisher at US$1.2 billion.
* GCL Asia is a leading video game distribution and publishing group in Asia, with more than 2100...
Notice convening the Annual General Meeting of AB Electrolux
STOCKHOLM, Feb. 20, 2023 /PRNewswire/ -- The shareholders of AB Electrolux, reg. no. 556009-4178, a...
PINTEC ANNOUNCES UNAUDITED FINANCIAL RESULTS FOR THE FIRST HALF OF 2022
BEIJING, Dec. 23, 2022 /PRNewswire/ -- Pintec Technology Holdings Limited (Nasdaq: PT) ("PINTEC" or...
Henlius Deepens Collaboration with Intas to bring Henlius' Novel anti-PD-1 mAb Serplulimab to Europe and India
* The footprint of serplulimab now includes the United States, Europe, Southeast Asia, MENA, and ...
Access to Novavax's COVID Vaccine Grows with Extended Interim Authorization for Adolescents in Singapore
GAITHERSBURG, Md., May 12, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company adva...
Novavax Submits Request to Expand Conditional Marketing Authorization of COVID-19 Vaccine in the European Union to Adolescents (Ages 12-17)
* If granted, Nuvaxovid™ COVID-19 Vaccine (recombinant, adjuvanted) would be the first protein-ba...